Higher baseline lipid levels amplify the benefit of secondary prevention therapy with statins in Chinese patients with acute coronary syndrome

OBJECTIVE: Statins are recommended as the first-line treatments for reducing the risk of major adverse cardiovascular events (MACE) in patients with acute coronary syndrome (ACS). The present study aimed to establish the baseline lipid levels associated with the greatest benefit from statin therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Ling, Liu, Ying, Zhang, Wei, Zhang, Zhu, Zhou, Liqin, Zhang, Hong, Zhang, Yong, Liu, Fuqiang, Liu, Peng, Liu, Zhongwei, Wang, Junkui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Retrospective Clinical Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780582/
https://www.ncbi.nlm.nih.gov/pubmed/33138662
http://dx.doi.org/10.1177/0300060520965848

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780582/
https://www.ncbi.nlm.nih.gov/pubmed/33138662
http://dx.doi.org/10.1177/0300060520965848

Ejemplares similares